Lexington, KY – May 6, 2011 – MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced that W. Craig Turner, Chairman and CEO of MedPro, will be presenting at two investor events in Florida next week. Mr. Turner will be speaking to investors in Ft. Lauderdale at noon on Wednesday, May 11 and Boca Raton at noon on Thursday, May 12. Investors interested in attending either event may contact Jenifer Kirtland at (415) 896-2005 or email@example.com.
“MedPro Safety has made significant progress over the past year and is now well positioned to move forward as a leader in the development of safe, effective blood collection and medication delivery systems,” said Mr. Turner. “We believe this is an opportune time to be more proactive with the investment community, communicating our story and opportunities more broadly so that investors have a better understanding of the Company’s potential.”
“We recently announced the launch of the VACUETTE® PREMIUM Safety Needle System Tube-Touch product that provides a safer alternative during blood collection to healthcare workers,” Mr. Turner continued. “This unique product is offered in partnership with Greiner Bio-One, our premier customer. The Tube-Touch system is the first of six products in various stages of development at MedPro that demonstrate our technology leadership and utilize our patented passive product design and automatic safety functionality. With a total available market of approximately 24 billion needles used worldwide in hospitals, acute care facilities and clinics, there is tremendous opportunity for MedPro.”
“We have a strong balance sheet and, with $18 million of net proceeds from a financing completed last year, cash to drive the commercialization of four new products in the pipeline that will allow us to expand into new markets beyond our current phlebotomy offerings. We look forward to our continued execution and we are optimistic that our success will result in enhanced valuation for our shareholders,” Mr. Turner concluded.
About MedPro Safety Products, Inc.
Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems. The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners. MedPro’s products address multiple product categories within the medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets. Unlike competitive products currently available on the market, MedPro’s products incorporate safety features that operate without user activation, and therefore require little or no clinician training to use. The total global market opportunity for safer medication delivery and blood collection products is believed to be more than $6 billion. For additional information, please refer to the ‘Investor Relations’ link on the Company’s website (http://www.medprosafety.com).
This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward- looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; our ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry. Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are used to identify forward-looking statements. We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form 10-K and our other reports on file with the Securities and Exchange Commission.
Doug Sherk/Jenifer Kirtland